ATE398288T1 - Hoch-durchsatz prion tests - Google Patents

Hoch-durchsatz prion tests

Info

Publication number
ATE398288T1
ATE398288T1 AT06006458T AT06006458T ATE398288T1 AT E398288 T1 ATE398288 T1 AT E398288T1 AT 06006458 T AT06006458 T AT 06006458T AT 06006458 T AT06006458 T AT 06006458T AT E398288 T1 ATE398288 T1 AT E398288T1
Authority
AT
Austria
Prior art keywords
sample
prpsc
followed
analysis
specific detection
Prior art date
Application number
AT06006458T
Other languages
English (en)
Inventor
Walter Eberle
Werner Stock
Baerbel Winter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE398288T1 publication Critical patent/ATE398288T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2828Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06006458T 2004-11-15 2005-11-14 Hoch-durchsatz prion tests ATE398288T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04027088 2004-11-15

Publications (1)

Publication Number Publication Date
ATE398288T1 true ATE398288T1 (de) 2008-07-15

Family

ID=34927388

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06006458T ATE398288T1 (de) 2004-11-15 2005-11-14 Hoch-durchsatz prion tests
AT06006457T ATE389182T1 (de) 2004-11-15 2005-11-14 Prion-assays mit hoher durchlaufleistung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06006457T ATE389182T1 (de) 2004-11-15 2005-11-14 Prion-assays mit hoher durchlaufleistung

Country Status (5)

Country Link
US (1) US7741054B2 (de)
EP (3) EP1674870B1 (de)
AT (2) ATE398288T1 (de)
CA (1) CA2523745C (de)
DE (2) DE602005005284T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010084201A1 (en) 2009-01-26 2010-07-29 Commissariat A L'energie Atomique Et Aux Energies Alternatives Novel derivative of erythromycin for the treatment and diagnosis of prion disease
CN103344760B (zh) * 2013-07-23 2015-08-26 成都安铂奥金生物科技有限公司 一种高通量免疫组化检测方法及多样品免疫组化检测板
EP2842962A1 (de) * 2013-08-30 2015-03-04 Ludwig-Maximilians-Universität München Verfahren zur Isolierung eines rekombinanten Prionproteins und Verwendung davon
EP3399034B1 (de) * 2017-05-05 2022-12-28 Siemens Healthcare Diagnostics Inc. Vorrichtung zur extraktion von nukleinsäuren aus biologischen probenmaterialien mit lösungsmittelfreien reagenzien

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
JP2848840B2 (ja) * 1989-03-03 1999-01-20 国際試薬株式会社 Gotアイソザイムの分別定量法
DE19730132C2 (de) * 1997-07-14 2000-01-20 Fraunhofer Ges Forschung Verfahren zum Nachweis von Prionen sowie eine Vorrichtung hierzu
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
DE10119713A1 (de) * 2001-04-21 2002-10-24 Prionics Ag Zuerich Verfahren zur Untersuchung von Prion-Protein enthaltenden Proben auf das eventuelle Vorliegen der PrPSc-Form
DE60212836T2 (de) * 2001-05-16 2007-01-25 Gpc Biotech Ag Pyridylpyrimidin-derivate als wirksame verbindungen gegen prionen-krankheiten
WO2003001211A1 (en) * 2001-06-22 2003-01-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for testing the presence of prion proteins in tissue and culture samples
WO2004046728A1 (en) * 2002-11-18 2004-06-03 Prionics Ag Method for the detection of prpsc

Also Published As

Publication number Publication date
CA2523745A1 (en) 2006-05-15
US7741054B2 (en) 2010-06-22
ATE389182T1 (de) 2008-03-15
CA2523745C (en) 2011-08-09
EP1674870A2 (de) 2006-06-28
EP1674870B1 (de) 2008-06-11
DE602005005284T2 (de) 2009-04-16
EP1677114A1 (de) 2006-07-05
EP1677115B1 (de) 2008-03-12
US20060121507A1 (en) 2006-06-08
DE602005005284D1 (de) 2008-04-24
EP1677115A2 (de) 2006-07-05
DE602005007458D1 (de) 2008-07-24
EP1677115A3 (de) 2006-09-20
EP1674870A3 (de) 2006-09-20

Similar Documents

Publication Publication Date Title
DE60028040D1 (de) Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs
TW200801515A (en) Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio- alzheimer's disease-specific molecular biomarkers (ADSMB)
RU2008136193A (ru) Детектирование рака по повышенным уровням bcl-2
DE69629292D1 (de) Verfahren zum feststellen der preparationsgüte von objektträgern und proben
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
WO2005086647A3 (en) Immuno-pcr method for the detection of a biomolecule in a test sample
WO2004097903A3 (en) Single tool defect classification solution
WO2010021822A3 (en) Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
DK1639130T3 (da) Prober, biblioteker og kits til analyse af blandinger af nukleinsyrer og metoder til opbygning af disse
DE602005017016D1 (de) Verfahren zur beurteilung der gefahr und veranlagung, eine mit dem vorliegen von anti-epcr-antikörpern verbundene symptomatik zu entwickeln
ATE398288T1 (de) Hoch-durchsatz prion tests
WO2007047029A3 (en) Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb)
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
WO2011037827A3 (en) Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
CN1864068B (zh) 用小表位抗体降低样品复杂度的方法
RU2011140006A (ru) Способ детекции вещества в биологическом образце
WO2008063663A3 (en) Poly (ethylene glycol) anti-body detection assays and kits for performing thereof
ATE462001T1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
KR20230079354A (ko) 단백질 또는 프로테옴의 존재 및/또는 농도 및/또는 양을 확인하는 방법
EP1560025A3 (de) Marker spezifisch für Diabetes
ATE354095T1 (de) Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand
JP6017724B1 (ja) 十二指腸液試料の膵液由来成分検出用試料としての適性評価方法
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties